| Date | Time | Source | Headline | Symbol | Company |
| 12/26/2018 | 7:01AM | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(g) (15-12g) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/26/2018 | 5:02AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/26/2018 | 5:02AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/26/2018 | 5:01AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/26/2018 | 5:01AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/26/2018 | 5:01AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/26/2018 | 5:01AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/26/2018 | 5:01AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/26/2018 | 5:01AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/26/2018 | 5:01AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/26/2018 | 5:01AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 3:42PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 3:41PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 3:38PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 3:38PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 3:38PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 3:38PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 3:37PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 3:35PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 3:33PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 3:33PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 3:04PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 2:54PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 8:20AM | Edgar (US Regulatory) | Post-effective Amendment to Proposed Securities Act Rule 462(b) Registration Statement (pos462b) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 8:17AM | Edgar (US Regulatory) | Post-effective Amendment to Proposed Securities Act Rule 462(b) Registration Statement (pos462b) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 8:13AM | Edgar (US Regulatory) | Post-effective Amendment to Proposed Securities Act Rule 462(b) Registration Statement (pos462b) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 8:09AM | Edgar (US Regulatory) | Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 7:25AM | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 7:24AM | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 7:20AM | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |